Filtros de búsqueda

Lista de obras de Michael Pfreundschuh

A CD16/CD30 bispecific monoclonal antibody induces lysis of Hodgkin's cells by unstimulated natural killer cells in vitro and in vivo

artículo científico publicado en 1993

A frequent target of paraproteins in the sera of patients with multiple myeloma and MGUS.

artículo científico publicado en 2009

A functional polymorphism in the NAD(P)H oxidase subunit CYBA is related to gene expression, enzyme activity, and outcome in non-Hodgkin lymphoma

artículo científico publicado en 2010

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

artículo científico publicado en 2008

A novel tumour associated leucine zipper protein targeting to sites of gene transcription and splicing

artículo científico publicado en 2002

A peptide epitope derived from the cancer testis antigen HOM-MEL-40/SSX2 capable of inducing CD4⁺ and CD8⁺ T-cell as well as B-cell responses

artículo científico publicado en 2011

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

artículo científico publicado en 1997

Accumulation of DNA Damage in Hematopoietic Stem and Progenitor Cells during Human Aging ⬇️

artículo científico publicado el 7 de marzo de 2011

Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial

artículo científico publicado en 2018

Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p

scientific article published on 08 December 2011

Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC.

artículo científico

Age and Sex in Non-Hodgkin Lymphoma Therapy: It's Not All Created Equal, or Is It?

artículo científico publicado en 2017

Age and cellular composition influence overall survival in a collective of non-immunocompromised patients with EBV-positive diffuse large B-cell lymphoma from a German lymphoma center

artículo científico publicado en 2016

Aggressive lymphoma: improving treatment outcome with rituximab.

artículo científico publicado en 2002

Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial

scientific article published on 07 May 2020

Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced disease

scientific article published on 09 November 2018

Analysis of the B-cell repertoire against antigens expressed by human neoplasms

artículo científico publicado en 2002

Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas

artículo científico publicado en 2002

Analysis of the antibody repertoire of lymphoma patients

artículo científico publicado en 2002

Analysis of the antibody repertoire of patients with mantle cell lymphoma directed against mantle cell lymphoma-associated antigens

artículo científico publicado en 2009

Angiotensin-receptor blockade, cancer, and concerns

Anti-CD16/CD30 bispecific antibody treatment for Hodgkin's disease: role of infusion schedule and costimulation with cytokines.

artículo científico publicado en 2001

Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice

artículo científico publicado en 1990

Application of recombinant antibodies in cancer patients.

artículo científico publicado en 2003

Aspects of chemotherapy schedules in young and elderly patients with aggressive lymphoma

artículo científico publicado en 2007

Association of NADPH oxidase polymorphisms with anthracycline-induced cardiotoxicity in the RICOVER-60 trial of patients with aggressive CD20(+) B-cell lymphoma

artículo científico publicado en 2015

Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study

artículo científico publicado en 2009

Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

article

Autoantibodies against lamin C, NA14 and CK15 in primary vasculitides or autoimmune diseases with secondary vasculitis

artículo científico publicado en 2016

Autoantigenic targets of B-cell receptors derived from chronic lymphocytic leukemias bind to and induce proliferation of leukemic cells ⬇️

artículo científico publicado el 11 de abril de 2013

Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group

artículo científico publicado en 2018

Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry

artículo científico publicado en 2008

Autosomal-dominant inheritance of hyperphosphorylated paratarg-7

artículo científico publicado en 2010

Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial

artículo científico

B-cell epitopes from the cancer testis antigen NY-ESO-1.

artículo científico publicado en 2006

Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial

artículo científico publicado en 2013

Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trial

artículo científico publicado en 2012

CD4⁺ T cells in chronic autoantigenic stimulation in MGUS, multiple myeloma and Waldenström's macroglobulinemia

artículo científico publicado en 2015

CHOP intensification: not yet state of the art.

artículo científico publicado en 2013

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

artículo científico publicado en 2006

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

artículo científico publicado en 2011

CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP.

artículo científico publicado en 2016

CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

artículo científico publicado en 2009

Characterization of Hap/BAG-1 variants as RP1 binding proteins with antiapoptotic activity

artículo científico publicado en 2005

Characterization of human colon cancer antigens recognized by autologous antibodies

artículo científico publicado en 1998

Characterization of human colon cancer antigens recognized by autologous antibodies

Characterization of the human GARP (Golgi associated retrograde protein) complex

artículo científico publicado en 2005

Circulating levels of TNF receptor II are prognostic for patients with peripheral T-cell non-Hodgkin lymphoma

artículo científico publicado en 2012

Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group

artículo científico

Clinical approaches to vaccination in oncology

artículo científico publicado en 2001

Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease ⬇️

artículo científico publicado el 1 de mayo de 1991

Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia

scientific article published on 26 July 2010

Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle c

artículo científico publicado en 2006

Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1) ⬇️

artículo científico publicado el 16 de noviembre de 2012

Correction: MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing

scholarly article by Gerhard Held et al published May 2008 in European Journal of Immunology

Cure of disseminated xenografted human Hodgkin's tumors by bispecific monoclonal antibodies and human T cells: the role of human T-cell subsets in a preclinical model

artículo científico publicado en 1996

Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cells

artículo científico publicado en 1994

Cytosine Arabinoside, Idarubicin and Divided Dose Etoposide for the Treatment of Acute Myeloid Leukemia in Elderly Patients ⬇️

artículo científico publicado el 1 de julio de 2001

Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV.

artículo científico publicado en 2013

Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV.

artículo científico publicado en 2018

Definition of tumor-associated antigens in hepatocellular carcinoma.

artículo científico publicado en 2000

Desmoplakin and KIF20B as target antigens in patients with paroxysmal nocturnal haemoglobinuria ⬇️

artículo científico publicado el 31 de agosto de 2010

Detection of Epstein-Barr virus DNA in Hodgkin- and Reed-Sternberg-cells by single cell PCR.

artículo científico publicado en 1994

Detection of Meningeosis neoplastica by real-time quantitation of telomerase activity

artículo científico publicado en 2009

Determination of optimum vitamin D3 levels for NK cell-mediated rituximab- and obinutuzumab-dependent cellular cytotoxicity

scientific article published on 21 August 2018

Diagnosis of pancreatic adenocarcinoma by polymerase chain reaction from pancreatic secretions

artículo científico publicado en 1994

Diagnostic and classification criteria in rheumatology: collagenoses

artículo científico publicado en 1996

Different apoptotic responses of RA synoviocytes depending on different genotypes of the mdm2 SNP T309G.

artículo científico publicado en 2012

Differential expression of cancer testis genes in histological subtypes of non-Hodgkin's lymphomas

artículo científico publicado en 2003

Differential presentation of tumor antigen-derived epitopes by MHC-class I and antigen-positive tumor cells

artículo científico publicado en 2008

Differential therapy for diffuse large B-cell lymphoma with different cells of origin

artículo científico publicado en 2009

Diffuse large B-cell lymphoma

artículo científico publicado en 2013

Direct evidence for a polygenic etiology in familial multiple myeloma

scientific article published on 07 April 2017

Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments

artículo científico publicado en 2004

Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib

artículo científico publicado en 2014

Docking of Lytic Granules at the Immunological Synapse in Human CTL Requires Vti1b-Dependent Pairing with CD3 Endosomes

artículo científico publicado en 2011

Dose-escalated CHOP plus etoposide (MegaCHOEP) followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphoma

artículo científico publicado en 2005

Dose-intensified treatment of advanced-stage diffuse large B-cell lymphomas

artículo científico publicado en 2006

Doubling rituximab in high-risk patients with aggressive B-cell lymphoma -results of the DENSE-R-MegaCHOEP trial

scientific article published on 05 December 2018

Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial

scientific article published on 28 December 2018

EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors

artículo científico publicado en 2013

Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial

scientific article published on 05 April 2012

Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study

scientific article published on 01 June 2008

Effects of physical exercise on myocardial telomere-regulating proteins, survival pathways, and apoptosis

artículo científico publicado en 2008

Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study

artículo científico publicado en 2017

Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study

artículo científico publicado en 2009

Elevated serum free light chains do not predict outcome of elderly patients with aggressive CD20(+) B-cell lymphomas

artículo científico publicado en 2014

Enrichment polymerase chain reaction for the detection of Ki-ras mutations: relevance of Taq polymerase error rate, initial DNA copy number, and reaction conditions on the emergence of false-positive mutant bands

artículo científico publicado en 1999

Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the

scientific article published on 28 June 2008

Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study

artículo científico publicado en 2009

Evaluation of ricin A chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's disease

artículo científico publicado en 1990

Evidence for a selected humoral immune response encoded by VH4 family genes in the synovial membrane of a patient with rheumatoid arthritis (RA).

artículo científico publicado en 1996

Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens

artículo científico publicado en 1999

Expression of SSX genes in human tumors

artículo científico publicado en 1998

Expression of cancer testis antigen CT45 in classical Hodgkin lymphoma and other B-cell lymphomas

artículo científico publicado en 2010

Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitis

artículo científico publicado en 2004

Expression of cancer testis genes in human brain tumors.

artículo científico publicado en 2000

Expression of cancer-testis genes in human hepatocellular carcinomas

artículo científico publicado el 19 de septiembre de 2002

Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: Basis for polyvalent CT vaccine strategies

artículo científico publicado en 1998

Expression of serologically identified tumor antigens in acute leukemias.

artículo científico publicado en 2003

Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor

artículo científico publicado en 2009

Factors predictive for response of follicular and mantle-cell lymphoma to rituximab

artículo científico publicado en 2006

First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial

artículo científico publicado en 2008

Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients w

artículo científico publicado en 2006

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

artículo científico publicado en 2020

Fourteen-day rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP-14): use it right or do not use it at all ⬇️

artículo científico publicado el 13 de febrero de 2012

Functional humanization of an anti-CD30 Fab fragment for the immunotherapy of Hodgkin's lymphoma using an in vitro evolution approach.

artículo científico publicado en 2004

Gastrointestinal perforation due to vasculitis at primary diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA) despite a high dose glucocorticosteroids treatment

artículo científico publicado en 2014

Gene-modified spontaneous Epstein-Barr virus-transformed lymphoblastoid cell lines as autologous cancer vaccines: mutated p21 ras oncogene as a model

artículo científico publicado en 2000

Genetic Variations in Genes Encoding RANK, RANKL, and OPG in Rheumatoid Arthritis: A Case-Control Study

article

Genetic polymorphism of the OPG gene associated with breast cancer ⬇️

artículo científico publicado el 31 de enero de 2013

Genetic variations in the genes encoding receptor activator nuclear factor κ B (RANK), receptor activator nuclear factor κ B ligand (RANKL) and osteoprotegerin (OPG) in patients with psoriasis and psoriatic arthritis: A case-control study ⬇️

artículo científico publicado el 2 de noviembre de 2010

Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells

artículo científico publicado en 2000

Growing importance of MYC/BCL2 immunohistochemistry in diffuse large B-cell lymphomas

artículo científico publicado en 2012

Hematology: germinal center or nongerminal center DLBCL?

artículo científico publicado en 2009

High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology.

artículo científico publicado en 2018

High rates of durable responses with anti-CD22 fractionated radioimmunotherapy: results of a multicenter, phase I/II study in non-Hodgkin's lymphoma

artículo científico publicado en 2010

High resolution copy number analysis of IRF4 translocation-positive diffuse large B-cell and follicular lymphomas

artículo científico publicado en 2012

High-dose chemotherapy and autologous stem-cell transplantation for DLBCL in the rituximab era

artículo científico publicado en 2017

High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial

artículo científico publicado en 2016

High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the European Blood and Marrow Transplantation Registry

artículo científico publicado en 2011

High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis

artículo científico publicado en 2013

Hodgkin and Reed-Sternberg cell associated monoclonal antibodies HRS-1 and HRS-2 react with activated cells of lymphoid and monocytoid origin

artículo científico publicado en 1988

Hodgkin and Reed-Sternberg cell-associated autoantigen CLIP-170/restin is a marker for dendritic cells and is involved in the trafficking of macropinosomes to the cytoskeleton, supporting a function-based concept of Hodgkin and Reed-Sternberg cells

artículo científico publicado en 2002

Hodgkin and Reed-Sternberg cells do not carry T-cell receptor gamma gene rearrangements: evidence from single-cell polymerase chain reaction examination

artículo científico publicado en 1995

How I treat elderly patients with diffuse large B-cell lymphoma

artículo científico publicado en 2010

How do estrogens control lymphoma?

artículo científico publicado en 2014

Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers

artículo científico publicado en 1998

Human neoplasms elicit multiple specific immune responses in the autologous host

artículo científico publicado en 1995

Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma

scientific article published on 24 September 2018

Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemia

artículo científico publicado en 2011

Hyperphosphorylation of autoantigenic targets of paraproteins is due to inactivation of PP2A ⬇️

artículo científico publicado el 26 de julio de 2011

Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens

artículo científico publicado en 1998

Identification of an HLA-A*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2.

artículo científico publicado en 2003

Identification of an HLA-DR-restricted peptide epitope with a promiscuous binding pattern derived from the cancer testis antigen HOM-MEL-40/SSX2.

artículo científico publicado en 2004

Identification of an antigenic peptide derived from the cancer-testis antigen NY-ESO-1 binding to a broad range of HLA-DR subtypes

artículo científico publicado en 2004

Identification of an epitope derived from the cancer testis antigen HOM-TES-14/SCP1 and presented by dendritic cells to circulating CD4+ T cells

artículo científico publicado en 2005

Identification of antigenic targets of paraproteins by expression cloning does not support a causal role of chronic antigenic stimulation in the pathogenesis of multiple myeloma and MGUS.

artículo científico publicado en 2007

Identification of genetic imbalances in malignant lymphoma using comparative genomic hybridization

artículo científico

Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B cell-type diffuse large B-cell lymphoma

scientific article published on 16 July 2020

Idiotype vaccine against Hodgkin's lymphoma: generation and characterization of an anti-idiotypic monoclonal antibody against the Hodgkin-associated (anti-CD 30) monoclonal antibody HRS-3

artículo científico publicado el 1 de mayo de 1991

Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL.

artículo científico publicado en 2010

Immunoglobulin V genes in Reed-Sternberg cells

artículo científico publicado en 1996

Immunotherapy of human tumors with T-cell-activating bispecific antibodies: stimulation of cytotoxic pathways in vivo

artículo científico publicado en 1999

Impact of Donor Activating KIR Genes on HSCT Outcome in C1-Ligand Negative Myeloid Disease Patients Transplanted with Unrelated Donors-A Retrospective Study

artículo científico publicado en 2017

Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV.

artículo científico publicado en 2011

Impact of rituximab and radiotherapy on outcome of patients with aggressive B-cell lymphoma and skeletal involvement

artículo científico publicado en 2013

Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML.

artículo científico publicado en 2015

Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) guidelines on the use of granulocyte colony-stimulating factor (G-CSF) for lymphoma care

scientific article published on January 2009

Inactivation of protein-phosphatase 2A causing hyperphosphorylation of autoantigenic paraprotein targets in MGUS/MM is due to an exchange of its regulatory subunits

artículo científico publicado en 2014

Incidence and inheritance of hyperphosphorylated paratarg-7 in patients with Waldenstrom's macroglobulinaemia in Sweden

artículo científico publicado en 2019

Increased levels of circulating cytokines in patients with untreated Hodgkin's disease

artículo científico publicado el 1 de abril de 1992

Increased levels of circulating interleukin-6 in patients with hodgkin's disease ⬇️

artículo científico publicado el 1 de noviembre de 1991

Influence of telomere length on short-term recovery after allogeneic stem cell transplantation

artículo científico publicado en 2005

Inheritance in MGUS and MM.

artículo científico publicado en 2015

Interleukin-12 increases bispecific-antibody-mediated natural killer cell cytotoxicity against human tumors.

artículo científico publicado en 1996

Intra-articular glucocorticosteroid injection into sternocostoclavicular joints in patients with SAPHO syndrome

artículo científico publicado el 5 de mayo de 2012

LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting

artículo científico publicado en 2018

Lack of evidence for a pathogenic role of Chlamydia pneumoniae and cytomegalovirus infection in coronary atheroma formation

scientific article published on October 1998

Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation

artículo científico publicado en 2008

Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials

artículo científico publicado en 2009

Low sensitivity of the ki-ras polymerase chain reaction for diagnosing pancreatic cancer from pancreatic juice and bile: a multicenter prospective trial

artículo científico publicado en 2002

Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma

scientific article published on 18 May 2020

MDM2 gene SNP309 T/G and p53 gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European Caucasians

artículo científico publicado en 2008

MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing

artículo científico publicado en 2007

MHC/Peptide-Specific Interaction of the Humoral Immune System: A New Category of Antibodies

artículo científico publicado en 2015

MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma ⬇️

artículo científico publicado el 18 de enero de 2013

Management of diffuse large B-cell lymphoma (DLBCL).

artículo científico

Mantle cell lymphoma: biological insights and treatment advances

scientific article published on August 2009

Matching for the MICA-129 polymorphism is beneficial in unrelated hematopoietic stem cell transplantation

artículo científico publicado en 2016

Mature T-cell and NK/T-cell neoplasms.

artículo científico publicado en 2005

MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas

artículo científico publicado en 2008

Mitofilin and titin as target antigens in melanoma-associated retinopathy

artículo científico publicado en 2007

Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study Gr

artículo científico publicado en 1998

Modified BEAM with triple autologous stem cell transplantation for patients with relapsed aggressive non-Hodgkin lymphoma

artículo científico publicado en 2016

Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease

artículo científico publicado en 1997

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

article

Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma: recent results and future prospects.

artículo científico publicado en 1997

Mutated Ras-transfected, EBV-transformed lymphoblastoid cell lines as a model tumor vaccine for boosting T-cell responses against pancreatic cancer: a pilot trial.

artículo científico publicado en 2012

N-ras genes are not mutated in Hodgkin and Reed-Sternberg cells: results from single cell polymerase chain-reaction examinations

artículo científico publicado en 1996

NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity

artículo científico publicado en 2005

Naturally occurring T-cell response against mutated p21 ras oncoprotein in pancreatic cancer

artículo científico publicado en 2006

New drugs for aggressive B-cell and T-cell lymphomas ⬇️

artículo científico publicado el 1 de noviembre de 2010

New perspectives in immunotherapy: adhesion molecules, superantigens, heat-shock proteins and cytokine antagonists

artículo científico publicado en 1992

Notch signaling

artículo científico publicado en 2007

Notch- and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell lines

artículo científico publicado en 2010

Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients

artículo científico publicado en 2015

Opposite effects of the CD30 ligand are not due to CD30 mutations: results from cDNA cloning and sequence comparison of the CD30 antigen from different sources

artículo científico publicado en 1994

Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients.

artículo científico publicado en 2017

Optimization of rituximab for the treatment of diffuse large B-cell lymphoma (II): extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the german high-grade non-Hodgkin lymphoma study group

artículo científico publicado en 2014

Outcome of Elderly Patients with Diffuse Large B-cell Lymphoma Treated with R-CHOP: Results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial

artículo científico publicado en 2017

Over one-third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal dominantly inherited risk factor for MGUS/MM.

artículo científico publicado en 2014

Palliative medical therapy of malignant diseases

scientific article published on 01 November 1989

Paraproteins of familial MGUS/multiple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent finding in familial and sporadic MGUS/MM ⬇️

artículo científico publicado el 17 de mayo de 2011

Parenthood in long-term survivors after CHOP with or without etoposide treatment for aggressive lymphoma

artículo científico publicado en 2014

Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma

artículo científico publicado en 2016

Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial

artículo científico publicado en 2017

Phenotypic and genotypic analysis of Hodgkin's disease derived cell lines: histopathological and clinical implications

artículo científico publicado en 1985

Prevalence of anti-citrullinated protein antibodies (ACPA) in patients with diffuse large B-cell lymphoma (DLBCL): a case-control study

artículo científico publicado en 2014

Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network

artículo científico publicado en 2016

Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium.

artículo científico publicado en 2017

Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium

artículo científico publicado en 2011

Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial G

article

Progranulin antibodies entertain a proinflammatory environment in a subgroup of patients with psoriatic arthritis

artículo científico publicado en 2013

Progranulin antibodies in autoimmune diseases ⬇️

artículo científico publicado el 11 de noviembre de 2012

Progranulin autoantibodies in systemic sclerosis and autoimmune connective tissue disorders: A preliminary study

scientific article published on 10 September 2019

Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient-Level Analysis of Multiple Randomized Trials (SEAL)

artículo científico publicado en 2018

Proinflammatory progranulin antibodies in inflammatory bowel diseases

artículo científico publicado en 2014

Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer.

artículo científico publicado en 2006

Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma

artículo científico publicado en 2002

Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

article

R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes

artículo científico publicado en 2014

RP1, a new member of the adenomatous polyposis coli-binding EB1-like gene family, is differentially expressed in activated T cells

artículo científico publicado en 1997

RUNX1 Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group ⬇️

artículo científico publicado el 22 de febrero de 2011

Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma

artículo científico publicado en 2002

Rapid reconstitution of CMV-specific T-cells after stem-cell transplantation.

artículo científico publicado en 2018

Rapidly Alternating COPP/ABV/IMEP Is Not Superior to Conventional Alternating COPP/ABVD in Combination With Extended-Field Radiotherapy in Intermediate-Stage Hodgkin’s Lymphoma: Final Results of the German Hodgkin’s Lymphoma Study Group Trial HD5 ⬇️

artículo científico publicado el 15 de enero de 2002

Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients

article

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

artículo científico publicado en 2012

Response: Intrathecal methotrexate and central nervous system events

artículo científico publicado en 2009

Risk of Japanese carriers of hyperphosphorylated paratarg‐7, the first autosomal‐dominantly inherited risk factor for hematological neoplasms, to develop monoclonal gammopathy of undetermined significance and multiple myeloma ⬇️

artículo científico publicado el 25 de enero de 2011

Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trial

scientific article published on 11 May 2014

Rituximab for the treatment of diffuse large B-cell lymphomas

artículo científico publicado en 2006

Rituximab in high-grade lymphoma

artículo científico publicado en 2010

Rituximab in patients with rheumatoid arthritis and vasculitis-associated cutaneous ulcers.

artículo científico publicado en 2010

Rituximab maintenance therapy in central nervous system lymphoma?

artículo científico publicado en 2009

Role of naive and memory T cells in tumor cell lysis mediated by Bi-specific antibodies ⬇️

artículo científico publicado el 1 de junio de 1997

Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma

artículo científico publicado en 2014

SSX: a multigene family with several members transcribed in normal testis and human cancer

artículo científico publicado en 1997

Saposin C is a frequent target of paraproteins in Gaucher disease-associated MGUS/multiple myeloma

artículo científico publicado en 2018

Secondary lymphomas of the central nervous system: risk, prophylaxis and treatment.

scientific article published on January 2008

Serological analysis of human tumor antigens: molecular definition and implications

artículo científico publicado en 1997

Serological identification of breast cancer-related antigens from a Saccharomyces cerevisiae surface display library

artículo científico publicado en 2005

Serological identification of human tumor antigens

artículo científico publicado en 1997

Serological immune response to cancer testis antigens in patients with pancreatic cancer

artículo científico publicado en 2006

Serum Antibodies against CD28– A New Potential Marker of Dismal Prognosis in Melanoma Patients ⬇️

artículo científico publicado el 6 de marzo de 2013

Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lymphomagenesis

artículo científico publicado en 2007

Significant dose Escalation of Idarubicin in the treatment of aggressive Non- Hodgkin Lymphoma leads to increased hematotoxicity without improvement in efficacy in comparison to standard CHOEP-14: 9-year follow up results of the CIVEP trial of the D

scientific article published on 03 January 2014

Single-nucleotide polymorphisms p53 G72C and Mdm2 T309G in patients with psoriasis, psoriatic arthritis, and SAPHO syndrome

artículo científico publicado en 2009

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).

artículo científico publicado en 2008

Specific activation of the prodrug mitomycin phosphate by a bispecific anti-CD30/anti-alkaline phosphatase monoclonal antibody

artículo científico publicado en 1990

Spontaneous high-titered IgG antibody responses against BCL-2 in patients with aggressive lymphomas

artículo científico publicado en 2009

Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era.

artículo científico publicado en 2010

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease

artículo científico publicado en 2003

Suboptimal dosing of rituximab in male and female patients with DLBCL.

artículo científico publicado en 2013

Successful treatment of disseminated aspergillosis with the combination of voriconazole, caspofungin, granulocyte transfusions, and surgery followed by allogeneic blood stem cell transplantation in a patient with primary failure of an autologous ste

artículo científico publicado en 2005

Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor

artículo científico publicado en 2014

Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor

artículo científico publicado en 2015

Sustained telomere erosion due to increased stem cell turnover during triple autologous hematopoietic stem cell transplantation

artículo científico publicado en 2007

T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28

artículo científico publicado en 1996

T-lymphocyte subpopulations in rheumatoid arthritis

artículo científico publicado en 1980

T-lymphocyte subpopulations in rheumatoid arthritis. II. Definition by monoclonal antibodies

scientific article published on 01 November 1981

TP53 mutation and survival in aggressive B cell lymphoma

artículo científico publicado en 2017

Targeted bioactivity of membrane-anchored TNF by an antibody-derived TNF fusion protein

artículo científico publicado en 2004

Targeting properties of an anti-CD16/anti-CD30 bispecific antibody in an in vivo system.

artículo científico publicado en 2001

The B lymphocyte in rheumatoid arthritis: analysis of rearranged Vx genes from B cells infiltrating the synovial membrane ⬇️

artículo científico publicado el 1 de octubre de 1995

The Clinical Significance of Cytokines and Soluble Forms of Membrane-Derived Activation Antigens in the Serum of Patients with Hodgkin's Disease ⬇️

artículo científico publicado el 1 de agosto de 1992

The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40

artículo científico publicado en 1996

The best treatment for diffuse large B-cell lymphoma: a German perspective.

artículo científico publicado en 2005

The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer

artículo científico publicado en 2007

The future of monoclonal antibody engineering ⬇️

artículo científico publicado el 1 de enero de 2001

The genealogy of SEREX

artículo científico publicado en 2012

The impact of Fc-γ receptor polymorphisms in elderly patients with diffuse large B-cell lymphoma treated with CHOP with or without rituximab ⬇️

artículo científico publicado el 7 de septiembre de 2011

The molecular basis for development of proinflammatory autoantibodies to progranulin

artículo científico publicado en 2015

The role of lymphocyte subsets and adhesion molecules in T cell-dependent cytotoxicity mediated by CD3 and CD28 bispecific monoclonal antibodies

artículo científico publicado en 1995

The role of radiotherapy and intrathecal CNS prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomas

artículo científico publicado en 2014

The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL ⬇️

artículo científico publicado el 15 de febrero de 2012

Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma

artículo científico publicado en 1997

Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults

artículo científico publicado en 2011

Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group

artículo científico publicado en 2010

Treatment of Hodgkin's disease with bispecific antibodies.

artículo científico publicado en 1996

Treatment of refractory Hodgkin's disease with an anti-CD16/CD30 bispecific antibody

artículo científico publicado en 1997

Treatment of refractory Hodgkin's disease with an anti-CD16/CD30 bispecific antibody

scientific article published on 01 March 1997

Tumour vaccines: a new immunotherapeutic approach in oncology

artículo científico publicado en 2000

Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial

artículo científico publicado en 2007

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.

artículo científico publicado en 2004

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL.

artículo científico publicado en 2004

USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma

artículo científico publicado en 2016

Unresolved issues in diffuse large B-cell lymphomas

artículo científico publicado en 2010

Use of spontaneous Epstein-Barr virus-lymphoblastoid cell lines genetically modified to express tumor antigen as cancer vaccines: mutated p21 ras oncogene in pancreatic carcinoma as a model

artículo científico publicado en 2002

VEGFR2 and VEGFA polymorphism are not associated with an inferior prognosis in Caucasian patients with aggressive B-cell lymphoma

scientific article published on 30 September 2020

Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab

artículo científico publicado en 2014

Wegener’s granuloma harbors B lymphocytes with specificities against a proinflammatory transmembrane protein and a tetraspanin ⬇️

artículo científico publicado el 14 de octubre de 2010

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extran

artículo científico publicado en 2017

Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV.

artículo científico publicado en 2013

[Current aspects of the diagnosis and therapy of Hodgkin's disease]

artículo científico publicado en 1986

[Immunotherapy of malignant diseases using interleukin 2. Bases, results, trends]

artículo científico publicado en 1990

[Intermediate results of therapy studies HD1, HD2 and HD3 of the German Hodgkin Study Group]

artículo científico publicado en 1986

[Ki-ras mutation as a molecular tumor marker for carcinoma of the pancreas]

artículo científico publicado en 1995

[New diagnostic and therapeutic strategies for aggressive lymphomas]

scientific article published on 01 October 2004

[Prognosis and therapy of Hodgkin's disease]

scientific article published on 01 April 1996

[Therapeutic strategies of Hodgkin's disease]

scientific article published on 01 February 1993

[Therapy of recurrent Hodgkin's lymphoma. I. Radiotherapy and conventional chemotherapy]

artículo científico publicado en 1989

[Therapy of recurrent Hodgkin's lymphoma. II. The value of bone marrow transplantation]

scientific article published on 01 June 1989

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda